In this study, based on the proposed systems biology methods, we selected NFKB1, LEF1, and MYC as drug targets for MIBC, and selected LEF1, MYC, NOTCH1, and FOXO1 as drug targets for ABC. This evidence concerns the gene NFKB1 and aneurysmal bone cyst.